Clinically relevant differences between amelanotic malignant melanoma and granuloma pyogenicum

Area of Science:

• Dermatology
• Oncology
• Pathology

Background:

• Macroscopic differentiation between amelanotic malignant melanoma (aMM) and pyogenic granuloma (GP) is often uncertain.
• Reliable criteria for distinguishing these growths are lacking, leading to diagnostic challenges.

Purpose of the Study:

• To identify and compare clinical criteria for differentiating cutaneous amelanotic malignant melanoma (aMM) from pyogenic granuloma (GP).
• To provide additional measures for clinical distinction between aMM and GP based on patient and lesion characteristics.

Main Methods:

• Retrospective analysis of 57 in-patients with cutaneous aMM and 83 with GP.
• Comparison of growth duration, site, patient age, and sex between the two groups.

Main Results:

• Significant differences (p<0.01) were found for all evaluated items.
• Pyogenic granuloma (GP) had a shorter median history (5 weeks) compared to amelanotic malignant melanoma (aMM) (26 weeks).
• aMM was more prevalent in older (>50 years), predominantly female patients (70%), while GP occurred equally across ages and sexes.
• Lesion site distribution differed, with GP common on the head/neck and rare on lower limbs, whereas aMM appeared in all areas but rarely on the trunk.

Conclusions:

• Clinical data on growth history, patient demographics, and lesion site offer valuable measures for distinguishing amelanotic malignant melanoma (aMM) from pyogenic granuloma (GP).
• These findings support improved diagnostic accuracy in differentiating these clinically similar skin lesions.